Stock A263050 EUTILEX.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
2,105 KRW -0.24% Intraday chart for Eutilex.Co.,Ltd +1.94% -37.72%
05-16 Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-21 Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Company Profile

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies.
Sector
Pharmaceuticals
Calendar
12/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

1st Jan change Capi.
EUTILEX.CO.,LTD Stock Eutilex.Co.,Ltd
-37.72% 56.01M
CSL LIMITED Stock CSL Limited
-1.91% 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.57B
UCB Stock UCB
+63.05% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.25B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.84B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 9.11B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-19.77% 7.32B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A263050 Stock
  4. Funds and ETFs Eutilex.Co.,Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW